BLDX yields 7.81% · JNJ yields 2.13%● Live data
📍 BLDX pulled ahead of the other in Year 1
Combined, BLDX + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BLDX + JNJ for your $10,000?
BLDX targets infrastructure businesses that support essential global systems and long-term sustainability themes through an actively managed equity portfolio. The fund invests in firms deriving significant revenues from infrastructure-related goods, services, or assets across areas such as clean energy, water systems, transportation, resource management, and data and communications. Portfolio construction combines fundamental financial analysis with ESG factors that the adviser considers financially material. The strategy is not limited to a single investment style and may hold growth, value, or blended exposures across different market capitalizations. BLDX invests globally, including a meaningful allocation to companies outside the US and may include emerging markets. Sector and regional positioning may shift over time, with potential exposure to areas such as industrials, utilities, and REITs. The fund converted from a mutual fund to an ETF with about $101 million in assets.
Full BLDX Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.